Stock listing

Duality Biotherapeutics, Inc.

Selected listing: 9606 · HKEX · HKD · HK

Duality Biotherapeutics, Inc. (HKEX:9606), Health Technology. Latest release Sep 30, 2026: An announcement has just been published by the issuer…

9606:HKEXHKDHKUpdated October 2, 2026

Ticker: HKEX:9606
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: HKEX
Currency: HKD

About Duality Biotherapeutics, Inc.

Duality Biotherapeutics, Inc. is a public company listed on the Hong Kong Stock Exchange under the ticker 9606. Duality Biotherapeutics focuses on developing innovative biotherapeutic solutions.

Latest news from Duality Biotherapeutics, Inc.

An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

September 30, 2026

Next Day Disclosure Return

September 29, 2026

Next Day Disclosure Return

September 28, 2026

2026 INTERIM REPORT

September 28, 2026

DualityBio Announces China NMPA Acceptance of Biologics License Application Seeking Approval for Trastuzumab Pamirtecan for the Treatment of Unresectable or Metastatic HER2-Positive Adult Breast Cancer

April 9, 2026

All Duality Biotherapeutics, Inc. news →

Research Duality Biotherapeutics, Inc.

Duality Biotherapeutics, Inc. company profile

View the public company page for Duality Biotherapeutics, Inc. on 6ix.

Duality Biotherapeutics, Inc. news

Read company news and market updates connected to Duality Biotherapeutics, Inc..

Duality Biotherapeutics, Inc. investor events

Find investor webinars, events, and replay context for Duality Biotherapeutics, Inc..